Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile
Andrew M. Evens, DO, MBA, MSc

@draevens

DD @RutgersCancer; AVChancellor @RutgersHealth; MedDir/Onc Lead @RWJBarnabas; EiC @e_JHaem; Lym VChair @eaonc; @lymphoma SAB;🇺🇸🇺🇦🇵🇱🇮🇹🇩🇪🇬🇷#BillsMafia

ID: 719175246050410496

linkhttps://linktr.ee/drandyevens calendar_today10-04-2016 14:48:35

6,6K Tweet

3,3K Followers

331 Following

eJHaem Journal (@e_jhaem) 's Twitter Profile Photo

Low-grade follicular lymphoma with interferon regulatory factor-4 rearrangement: Expanding the spectrum of interferon regulatory factor-4-rearranged lymphomas buff.ly/3AAIcqc

Low-grade follicular lymphoma with interferon regulatory factor-4 rearrangement: Expanding the spectrum of interferon regulatory factor-4-rearranged lymphomas buff.ly/3AAIcqc
Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile Photo

Survivorship preparedness and activation among survivors of lymphoma by Rutgers Cancer Institute Dr DrManne ➡️SEE: rdcu.be/dSigi >40% NOT activated for #survivorship (understanding one’s role...having the knowledge, skill, and confidence...in managing lymphoma self-care)

Survivorship preparedness and activation among survivors of lymphoma by <a href="/RutgersCancer/">Rutgers Cancer Institute</a> Dr <a href="/sharonlyn7789/">DrManne</a>

➡️SEE: rdcu.be/dSigi

&gt;40% NOT activated for #survivorship (understanding one’s role...having the knowledge, skill, and confidence...in managing lymphoma self-care)
Dr. John Cush (@rheumnow) 's Twitter Profile Photo

It takes >3-4 weeks of steroids (@ any dose >5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of <3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6

It takes &gt;3-4 weeks of steroids (@ any dose &gt;5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of &lt;3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6
Tatiana Prowell, MD (@tmprowell) 's Twitter Profile Photo

If you’re reading this, you’re a year 4 pandemic survivor. #Gratitude to the scientists & clinical trial participants who brought the world #COVID19 #vaccines in record time. Look at 🇺🇸 top 10 causes of death from 2019 to 2023. #VaccinesWork #MedTwitter jamanetwork.com/journals/jama/…

If you’re reading this, you’re a year 4 pandemic survivor. #Gratitude to the scientists &amp; clinical trial participants who brought the world #COVID19 #vaccines in record time. Look at 🇺🇸 top 10 causes of death from 2019 to 2023. #VaccinesWork #MedTwitter

jamanetwork.com/journals/jama/…
Andrew M. Evens, DO, MBA, MSc (@draevens) 's Twitter Profile Photo

That is not always true, Aaron Goodman - “Papa Heme”. It should not be "us" vs "them" (physicians & administration, etc). I was at a similar dissident crossroads ~12-13 yrs ago as you are in seeing inefficiency in #cancer healthcare (overall and esp. for oncologists). I obtained an

Lymphoma Research Foundation (@lymphoma) 's Twitter Profile Photo

Did you know that every 5 minutes, someone in the U.S. is diagnosed with lymphoma? Join us in raising awareness and spreading education as we work toward eradicating lymphoma during #BloodCancerAwarenessMonth.

Did you know that every 5 minutes, someone in the U.S. is diagnosed with lymphoma? Join us in raising awareness and spreading education as we work toward eradicating lymphoma during #BloodCancerAwarenessMonth.
Culture Explorer (@cultureexplorex) 's Twitter Profile Photo

Germany is home to some of the most breathtaking towns and villages on Earth. Here are 20 that will blow your mind and make you wonder why you haven’t visited them yet. 🧵

Germany is home to some of the most breathtaking towns and villages on Earth. 

Here are 20 that will blow your mind and make you wonder why you haven’t visited them yet. 🧵
Michael Makris (@profmakris) 's Twitter Profile Photo

Rituximab refractory or intolerant immune TTP cases are very difficult to manage. Paper in British Journal of Haematology from France suggest that Daratumumab is a reasonable therapeutic option. tinyurl.com/59p7ybwt #TTP #daratumumab

Rituximab refractory or intolerant immune TTP cases are very difficult to manage. Paper in <a href="/BrJHaem/">British Journal of Haematology</a> from France suggest that Daratumumab is a reasonable therapeutic option. tinyurl.com/59p7ybwt #TTP #daratumumab
eJHaem Journal (@e_jhaem) 's Twitter Profile Photo

Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemia buff.ly/3AHNLmN

Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemia 
buff.ly/3AHNLmN